Skip to main content
Signal8

YK Bioventures Opportunities GP I, LLC

SEC insider (Form 3/4/5 filer). CIK 0002042634. 10% Owner at CERO THERAPEUTICS HOLDINGS, INC. (CERO). 7 reported Form 4/5 transactions since Sep 2024; latest on Dec 13, 2024. Located in BURLINGAME, CA.

Companies YK Bioventures Opportunities GP I, LLC has filed insider reports for

  • CERO THERAPEUTICS HOLDINGS, INC. (CERO): 10% Owner
YK Bioventures Opportunities GP I, LLC profile photo

YK Bioventures Opportunities GP I, LLC

CIK: 0002042634

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CERO THERAPEUTICS HOLDINGS, INC. logo
CERO

CERO THERAPEUTICS HOLDINGS, INC.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Dec 13, 2024
    Sale
    Indirect
    3M shares at avg. $0.06$180K
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Dec 12, 2024
    Sale
    Indirect
    1.6M shares at avg. $0.07$113K
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Dec 11, 2024
    Sale
    Indirect
    1.3M shares at avg. $0.08$108K
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Dec 10, 2024
    Sale
    Indirect
    1.6M shares at avg. $0.09$141K
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Dec 9, 2024
    Sale
    Indirect
    850.5K shares at avg. $0.11$94K
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Dec 6, 2024
    Sale
    Indirect
    1.2M shares at avg. $0.12$148K
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Oct 10, 2024
    Sale
    Indirect
    3.3M shares at avg. $0.10$325K

1-7 of 7